{"disease":{"id":"vlcad-deficiency","name":"vlcad deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02214160","title":"Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":true},{"nct_id":"NCT01886378","title":"A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":true},{"nct_id":"NCT03531554","title":"Acute Nutritional Ketosis in VLCAD Deficiency","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT01461304","title":"Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Jerry Vockley, MD, PhD","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}